GlassScriptPhysician profile
C Alexander Carrasquer
NPI 1972036218
$918.53
in general payments reported to CMS, 2019-2025
23 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.69 · 2021: $34.78 · 2022: $13.14 · 2023: $319 · 2024: $328 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $229.68 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Merz Pharmaceuticals, LLC | $107.91 | 2023 | Xeomin |
| Merz North America, INC. | $66.91 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $56.42 | 2023-2025 | Exparel, Iovera, Zilretta |
| Abbvie INC. | $54.27 | 2023-2024 | Teflaro, Dalvance |
| Smith+Nephew, INC. | $41.87 | 2023-2024 | Renasys Go V2 Home, Renasys Touch, Pico 14 |
| Depuy Synthes Sales INC. | $41.42 | 2025 | Orthovisc, Monovisc, Multiloc |
| Melinta Therapeutics, LLC | $30.68 | 2023 | Orbactiv, Kimyrsa |
| Convatec INC. | $27.43 | 2024 | |
| Avanos Medical | $23.21 | 2025 | On-Q Pump and Accessories |
| Medtronic, INC. | $22.63 | 2023 | Synchromedii |
| Abbott Laboratories | $22.48 | 2024 | Octrode |
| Vertex Pharmaceuticals Incorporated | $22.44 | 2025 | |
| Lifenet Health | $22.36 | 2025 | Theragenesis Wound Matrix |
| Ultragenyx Pharmaceutical INC. | $21.42 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $19.34 | 2024 | Evoke |
| Ferring Pharmaceuticals INC. | $18.72 | 2024 | Euflexxa |
| Kerecis Limited | $18.68 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $17.19 | 2025 | |
| Kci USA, INC. | $14.07 | 2023 | Prevena, Prevena Restor Arthroform |
| Dynasplint Systems INC. | $13.70 | 2024 | Dynasplint |
| Aurinia Pharma U.S., INC. | $13.14 | 2022 | |
| Allergan, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw C Carrasquer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.